Advertisement
  • Loading metrics

Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding

  • Kristen M. Kahle,

    Affiliation Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

  • H. Kirby Steger,

    Current address: Department of Protein Therapeutics Development, Bristol-Myers-Squibb, Pennington, New Jersey, United States of America

    Affiliation Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

  • Michael J. Root

    michael.root@jefferson.edu

    Affiliation Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding

  • Kristen M. Kahle, 
  • H. Kirby Steger, 
  • Michael J. Root
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.